rs138931498
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_032977.4(CASP10):c.953G>A(p.Gly318Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000259 in 1,608,688 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032977.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP10 | NM_032977.4 | c.953G>A | p.Gly318Glu | missense_variant | Exon 9 of 10 | ENST00000286186.11 | NP_116759.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000213 AC: 32AN: 150030Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000251 AC: 62AN: 247220Hom.: 0 AF XY: 0.000224 AC XY: 30AN XY: 133768
GnomAD4 exome AF: 0.000264 AC: 385AN: 1458658Hom.: 2 Cov.: 36 AF XY: 0.000260 AC XY: 189AN XY: 725822
GnomAD4 genome AF: 0.000213 AC: 32AN: 150030Hom.: 0 Cov.: 31 AF XY: 0.000192 AC XY: 14AN XY: 73014
ClinVar
Submissions by phenotype
not specified Uncertain:1
DNA sequence analysis of the CASP10 gene demonstrated a sequence change, c.953G>A, in exon 9 that results in an amino acid change, p.Gly318Glu. This sequence change does not appear to have been previously described in patients with CASP10-related disorders and has been described in the gnomAD database with a population frequency of 0.054% in the non-Finish European subpopulation (dbSNP rs138931498). The p.Gly318Glu change affects a highly conserved amino acid residue located in a domain of the CASP10 protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Gly318Glu substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Gly318Glu change remains unknown at this time. -
Autoimmune lymphoproliferative syndrome type 2A Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 318 of the CASP10 protein (p.Gly318Glu). This variant is present in population databases (rs138931498, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CASP10-related conditions. ClinVar contains an entry for this variant (Variation ID: 535758). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CASP10 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at